CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- S-1 Offering Registration Statement
- 8-K Event Agreement ended
- 4 Open-market buy Exec. Vice Chairman/CEO/Pres. bought 20,000 shares at an average $0.19 ($3,845)
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Grant or award Dir Govt Relations/Sectry acquired 2,500 shares (grant or award)
- 4 Grant or award Exec. Vice Chairman/CEO/Pres. acquired 2,500 shares (grant or award)
- 4 Grant or award Chief Science/Medical Officer acquired 2,500 shares (grant or award)
- 4 Grant or award Sr. VP of Operations acquired 2,500 shares (grant or award)
- 4 Grant or award CFO acquired 2,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 4 Insider Changes in Ownership
Page 32 of 82 · 1,637 filings